Aligos Therapeutics, Inc. · NASDAQ:ALGS
Sio Capital Management, LLC reported a 5.46% stake in Aligos Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Sio Capital Management, LLC reported a 5.46% stake in Aligos Therapeutics, Inc., 335,937 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 5.46%
- Shares
- 335,937
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sio Capital Management, LLC | 5.46% | 335,937 |
Source
Related
- Aligos Therapeutics, Inc.
- Sio Capital Management, LLC
- Aligos Therapeutics, Inc. shareholders
- Schedule 13G · Sio Capital Management, LLC · Aug 13, 2025
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Lawrence M. Blatt · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Woodline Partners LP · Nov 14, 2025